Publicaciones en las que colabora con Alberto Ocaña (5)

2021

  1. Altered proTGFα/cleaved TGFα ratios offer new therapeutic strategies in renal carcinoma

    Journal of Experimental and Clinical Cancer Research, Vol. 40, Núm. 1

2018

  1. Refining Early Antitumoral Drug Development

    Trends in Pharmacological Sciences

  2. Resistance to antibody–drug conjugates

    Cancer Research, Vol. 78, Núm. 9, pp. 2159-2165

2017

  1. Resistance to the antibody–drug conjugate T-DM1 is based in a reduction in lysosomal proteolytic activity

    Cancer Research, Vol. 77, Núm. 17, pp. 4639-4651

2015

  1. Identification of therapeutic targets in ovarian cancer through active tyrosine kinase profiling

    Oncotarget, Vol. 6, Núm. 30, pp. 30057-30071